Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01974050 · ClinicalTrials.gov registry record · NA
PregText: Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 166
- Enrollment target
NCT01974050 is a NA study that has completed, run by Columbia University. The registered enrollment target is 166 participants.
The verdict
NCT01974050, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
Study Summary
In this study, the investigators will prospectively assess fever rates and other adverse events in pregnant women after administration of inactivated influenza vaccine (IIV) using text messaging. The investigators hypothesize that women \<20 weeks gestational age who receive IIV will be willing to enroll in a text messaging-based vaccine adverse event monitoring program and will use it to report fever in the post-vaccination period as well as continue to text pregnancy-related outcomes through the end of their pregnancy.
Interventions
- BEHAVIORAL Text message surveillance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2013-11 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01974050
The ClinicalTrials.gov registry entry for NCT01974050 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Text message surveillance is the first listed.
NCT01974050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01974050 about?
NCT01974050 is a clinical study titled "PregText: Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging". In this study, the investigators will prospectively assess fever rates and other adverse events in pregnant women after administration of inactivated influenza vaccine (IIV) using text messaging. The investigators hypothesize that women \<20 weeks gestational age who receive IIV will be willing to e...
What is the current status of trial NCT01974050?
This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2013-11. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01974050?
The interventions under investigation include: Text message surveillance (BEHAVIORAL).
Who is sponsoring clinical trial NCT01974050?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.